# Efficacy and Safety of Fecal Microbiota Transplantation for Severe Clostridium Difficile Associated Colitis

> **NCT01959048** · NA · TERMINATED · sponsor: **Hadassah Medical Organization** · enrollment: 3 (actual)

## Conditions studied

- Clostridium Difficile

## Interventions

- **DRUG:** fecal microbiota transplantation

## Key facts

- **NCT ID:** NCT01959048
- **Lead sponsor:** Hadassah Medical Organization
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-04
- **Primary completion:** 2016-01
- **Final completion:** 2016-01
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** FMT for study indication has been permitted by Israeli Ministry of Health
- **Last updated:** 2019-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01959048

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01959048, "Efficacy and Safety of Fecal Microbiota Transplantation for Severe Clostridium Difficile Associated Colitis". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT01959048. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*